| Primary |
| Type 2 Diabetes Mellitus |
39.7% |
| Diabetes Mellitus |
38.3% |
| Hypertension |
7.6% |
| Diabetes Mellitus Non-insulin-dependent |
3.8% |
| Blood Glucose |
1.7% |
| Product Used For Unknown Indication |
1.1% |
| Dyslipidaemia |
1.1% |
| Hyperlipidaemia |
0.9% |
| Hyperglycaemia |
0.7% |
| Blood Glucose Increased |
0.7% |
| Blood Glucose Abnormal |
0.7% |
| Hypercholesterolaemia |
0.6% |
| Cardiac Failure |
0.4% |
| Pain |
0.4% |
| Atrial Fibrillation |
0.4% |
| Hyperuricaemia |
0.4% |
| Diabetes Mellitus Inadequate Control |
0.3% |
| Gastrooesophageal Reflux Disease |
0.3% |
| Insomnia |
0.3% |
| Blood Cholesterol Increased |
0.3% |
|
| Pancreatitis |
17.5% |
| Hypoglycaemia |
8.1% |
| Blood Glucose Increased |
8.0% |
| Drug Ineffective |
7.6% |
| Rash |
6.6% |
| Wrong Technique In Drug Usage Process |
5.2% |
| Weight Decreased |
4.8% |
| Pancreatic Carcinoma |
4.8% |
| Nausea |
4.7% |
| Headache |
4.6% |
| Vomiting |
4.0% |
| Rhinorrhoea |
3.3% |
| Pancreatitis Acute |
3.2% |
| Weight Increased |
3.2% |
| Oedema Peripheral |
2.6% |
| Upper Respiratory Tract Infection |
2.6% |
| Diarrhoea |
2.4% |
| Renal Failure Acute |
2.3% |
| Myalgia |
2.3% |
| Interstitial Lung Disease |
2.3% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
36.0% |
| Diabetes Mellitus |
25.3% |
| Product Used For Unknown Indication |
10.7% |
| Hypertension |
9.4% |
| Drug Use For Unknown Indication |
1.9% |
| Constipation |
1.7% |
| Hypercholesterolaemia |
1.4% |
| Hyperlipidaemia |
1.2% |
| Cardiac Failure |
1.2% |
| Hyperglycaemia |
1.2% |
| Atrial Fibrillation |
1.1% |
| Diabetes Mellitus Non-insulin-dependent |
1.1% |
| Blood Glucose Increased |
1.1% |
| Prophylaxis |
1.0% |
| Chronic Myeloid Leukaemia |
1.0% |
| Congestive Cardiomyopathy |
1.0% |
| Dyslipidaemia |
0.9% |
| Hyperuricaemia |
0.9% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Blood Glucose |
0.9% |
|
| Wrong Technique In Drug Usage Process |
10.4% |
| Hypoglycaemia |
10.0% |
| Pancreatitis |
8.7% |
| Pancreatic Carcinoma |
7.5% |
| Blood Glucose Increased |
6.5% |
| Renal Failure Acute |
6.1% |
| Weight Decreased |
5.9% |
| Pancreatitis Acute |
5.1% |
| Rash |
4.7% |
| Rhabdomyolysis |
4.5% |
| Liver Disorder |
4.1% |
| Overdose |
4.1% |
| Drug Ineffective |
3.7% |
| Vomiting |
3.5% |
| Weight Increased |
3.5% |
| Oedema Peripheral |
2.6% |
| Pruritus |
2.6% |
| Glycosylated Haemoglobin Increased |
2.4% |
| Rhinorrhoea |
2.2% |
| Drug Hypersensitivity |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.2% |
| Diabetes Mellitus |
17.0% |
| Drug Use For Unknown Indication |
9.7% |
| Type 2 Diabetes Mellitus |
9.2% |
| Hypertension |
9.1% |
| Blood Cholesterol Increased |
2.9% |
| Rheumatoid Arthritis |
2.8% |
| Pain |
2.6% |
| Atrial Fibrillation |
2.3% |
| Hepatitis C |
2.1% |
| Depression |
1.8% |
| Prophylaxis |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Cardiac Disorder |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Hyperlipidaemia |
1.0% |
| Osteoporosis |
1.0% |
| Hypothyroidism |
1.0% |
| Blood Pressure |
0.9% |
| Vitamin Supplementation |
0.9% |
|
| Weight Decreased |
10.1% |
| Vomiting |
9.9% |
| Blood Glucose Increased |
8.2% |
| Weight Increased |
6.3% |
| Death |
5.7% |
| Rash |
5.5% |
| Nausea |
5.0% |
| Myocardial Infarction |
4.9% |
| Drug Ineffective |
4.8% |
| Flushing |
4.7% |
| Pneumonia |
4.7% |
| Pain |
4.0% |
| Pruritus |
3.8% |
| Urinary Tract Infection |
3.8% |
| Renal Failure Acute |
3.5% |
| Pain In Extremity |
3.4% |
| Renal Failure |
3.4% |
| Diarrhoea |
2.8% |
| Cerebrovascular Accident |
2.7% |
| Paraesthesia |
2.7% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
34.5% |
| Pain |
10.9% |
| Parkinson's Disease |
9.1% |
| Diabetes Mellitus |
7.3% |
| Dyslipidaemia |
7.3% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Erectile Dysfunction |
3.6% |
| Hypercholesterolaemia |
3.6% |
| Hypertension |
3.6% |
| Nausea |
3.6% |
| Atrial Fibrillation |
1.8% |
| Cardiac Disorder |
1.8% |
| Haemorrhoids |
1.8% |
| Hyperlipidaemia |
1.8% |
| Iron Deficiency |
1.8% |
| Pernicious Anaemia |
1.8% |
| Reflux Oesophagitis |
1.8% |
|
| Drug Interaction |
21.4% |
| Hepatic Enzyme Increased |
14.3% |
| Hypoglycaemia |
14.3% |
| Weight Decreased |
14.3% |
| Paraesthesia |
7.1% |
| Syncope |
7.1% |
| Vision Blurred |
7.1% |
| Vomiting |
7.1% |
| Weight Increased |
7.1% |
|
